Related Experiment Videos
Two-dimensional pencil beam scaling: an improved proton dose algorithm for heterogeneous media.
Hanitra Szymanowski1, Uwe Oelfke
1Deutsches Krebsforschungszentrum DKFZ, Department of Medical Physics, Heidelberg, Germany. h.szymanowski@dkfz.de
Physics in Medicine and Biology
|October 12, 2002
Summary
A new proton dose algorithm improves accuracy in proton therapy planning. This method enhances dose calculations for complex patient anatomy, approaching Monte Carlo simulation accuracy with faster computation times.
Area of Science:
- Medical Physics
- Radiation Oncology
- Computational Biology
Background:
- Proton beam therapy requires fast and accurate dose algorithms for treatment plan optimization.
- Current methods struggle with accuracy in heterogeneous anatomical regions.
- Existing fast algorithms lack the precision needed for clinical dose distributions.
Purpose of the Study:
- To develop a novel proton dose calculation algorithm addressing the speed-accuracy trade-off.
- To improve dose calculation accuracy for complex and heterogeneous targets in proton therapy.
- To enable clinically acceptable dose distributions in conformal proton therapy.
Main Methods:
- A new algorithm based on additional scaling of lateral proton fluence was derived.
- A two-dimensional (2D) scaling method was developed and tested.
- The new method was compared against standard pencil beam calculations and Monte Carlo simulations (GEANT).
Main Results:
- The new algorithm achieves absorbed dose calculation accuracy comparable to Monte Carlo simulations.
- The computational time is only modestly increased compared to standard pencil beam methods.
- The 2D scaling method demonstrated effectiveness across various phantom materials, including bone, muscle, fat, and air.
Conclusions:
- The new proton dose algorithm offers a significant improvement in accuracy for proton therapy.
- It provides a viable solution for optimizing treatment plans in complex clinical cases.
- This algorithm has the potential to enhance outcomes in highly conformal proton therapy.